Octapharma AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Octapharma AG (Octapharma or 'the company') is involved in the development, manufacture, and marketing of human proteins for use in pharmaceuticals and medical treatments. The company’s product portfolio comprises protein and other biopharmaceutical products derived from human plasma in hematology, critical care, and immunotherapy therapeutic areas. The company operates manufacturing facilities and R&D centers in Austria, France, the US, Germany, and Mexico. The company also offers the services of collecting plasma for life saving plasma derived therapies. It operates in Europe, the Americas, Asia Pacific and the Middle East. Octapharma is headquartered in Lachen, Schwyz, Switzerland.
Scope
Detailed information on Octapharma AG required for business and competitor intelligence needs
A study of the major internal and external factors affecting Octapharma AG in the form of a SWOT analysis
An in-depth view of the business model of Octapharma AG including a breakdown and examination of key business segments
Intelligence on Octapharma AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Octapharma AG, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Octapharma AG and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Octapharma AG as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Octapharma AG's business structure, strategy and prospects.
Company Snapshot
Octapharma AG: Company Overview
Octapharma AG: Overview and Key Facts
Octapharma AG: Overview
Octapharma AG: Key Facts
Octapharma AG: Key Employees
Octapharma AG: Major Products and Services
Octapharma AG: Management Statement
Octapharma AG: Locations and Subsidiaries
Octapharma AG: Key Competitors
Octapharma AG: Company Analysis
Octapharma AG: Business Description
Octapharma AG: SWOT Analysis
Octapharma AG: SWOT Overview
Octapharma AG: Strengths
Octapharma AG: Weaknesses
Octapharma AG: Opportunities
Octapharma AG: Threats
Octapharma AG: Corporate Financial Deals Activity
Octapharma AG: Financial Deals Overview
Octapharma AG: Targets and Partners
Octapharma AG: Top Deals 2020 - 2024YTD*
Octapharma AG: Partnership
Octapharma AG: Recent Developments
Octapharma AG: News and Events Summary
Octapharma AG: Contracts
Octapharma AG: Financial Deals
Octapharma AG: Market Developments
Octapharma AG: Research & Development
Octapharma AG: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Octapharma AG: Key Facts
Table 2: Octapharma AG: Key Employees
Table 3: Octapharma AG: Locations and Subsidiaries
Table 4: Octapharma AG: Key Competitors
Table 5: Octapharma AG: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 6: Octapharma AG: Targets and Partners
Table 7: Octapharma AG: Top Deals 2020 - 2024YTD*
Table 8: Octapharma AG: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 9: Octapharma AG: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 10: Octapharma AG: News and Events Summary
Table 11: Octapharma AG: Contracts
Table 12: Octapharma AG: Financial Deals
Table 13: Octapharma AG: Market Developments
Table 14: Octapharma AG: Research & Development
Table 15: Octapharma AG: Strategy and Operations
List of Figures
Figure 1: Octapharma AG: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 2: Octapharma AG: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 3: Octapharma AG: Partnership Trend by Deal Type (2020 - YTD*2024)